Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand RJ Girbes, Pieter M ter Wee, AB Johan Groeneveld, for the CASH study group;Louise Schilder;S Azam Nurmohamed;Frank H Bosch;Ilse M Purmer;Sylvia S den Boer;Cynthia G Kleppe;Marc G Vervloet;Albertus Beishuizen;Armand RJ Girbes;Pieter M ter Wee;AB Johan Groeneveld;for the CASH study group;
critical care 2014 Vol. 18 pp. -
168
group2014criticalcitrate

Abstract

Because of ongoing controversy, renal and vital outcomes are compared between systemically administered unfractionated heparin and regional anticoagulation with citrate-buffered replacement solution in predilution mode, during continuous venovenous hemofiltration ...

Keywords

Citation

ID: 270472
Ref Key: group2014criticalcitrate
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
270472
Unique Identifier:
10.1186/s13054-014-0472-6
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet